The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
The possibility of setting up a positron emission tomography (PET) facility with a cyclotron and radiopharmaceutical laboratory in situ, at a feasible price and in a very restricted space, has led to a steady increase both in the use of the PET technique in diagnostic clinical routine imaging and in the number of cyclotrons for drug production. Owing to the progress made in the PET procedures, it is now possible to have not only a highly innovative system of diagnostic examination, with a remarkable improvement in the diagnostic quality and patient care, but also a considerable increase in the number of daily examinations. In this paper, the authors show how the acquired know-how, with respect to radioprotection, has applied to the planning, running and management of the PET/CT unit, installed in the Imaging Diagnostic Department of the Policlinico Tor Vergata (PTV), at Tor Vergata University, Rome.
Institute of Biomedical Engineering, National Research Council, Area della Ricerca di Roma 1, Via Salaria Km 29,300 CP 10-00015 Monterotondo Stazione, Rome, Italy. russo@isib.cnr.it
A A
AA
Russo
P
P
Ferrari
M
M
Casale
R
R
Delia
D017357:Cyclotrons / Q000592:standards*; D019788:Fluorodeoxyglucose F18 / Q000592:standards; D006801:Humans; D009683:Nuclear Medicine / Q000592:standards*; D016273:Occupational Exposure / Q000517:prevention & control*; D049268:Positron-Emission Tomography / Q000592:standards*; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000517:prevention & control*; D011835:Radiation Protection / Q000331:legislation & jurisprudence*; D019275:Radiopharmaceuticals / Q000592:standards*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18